Subspecialties

Using tear osmolarity and MMP-9 as the basis of an ocular surface disease treatment algorithm

Enter the enhanced world of augmented reality…

Aflibercept’s newly approved administration regime permits a reduction in intravitreal injection frequency

NICE offers new option for retinal dystrophy patients

15-year study uncovers first known genetic cause for rare retinal disease

Sitting Down With… Ravi Goel, Ophthalmic Surgeon, Wills Eye Hospital, USA

Topical piezo-print technology could solve many of the problems associated with use of topical eye medications

Diabetes prevalence is set to grow by 48 percent over the next 25 years – so where does that leave ophthalmologists?

What does the future hold for the management – and treatment – of diabetic eye disease?

Capabilities of the new SPECTRALIS High Magnification Module